Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a chronic inflammatory liver disorder without effective medical treatment which is characterized by inflammation and fibrotic structures around the bile ducts. Biliary epithelial cells (cholangiocytes) are the target and potential disease drivers in PSC, yet little is known if cholangiocytes from PSC patients differ from non-PSC controls. To characterize cholangiocytes at early rather than end-stage disease, cholangiocyte organoids (COs) were derived from diseased bile ducts of PSC patients and compared to organoids generated from disease controls. METHODS: Cholangiocytes were obtained during endoscopic retrograde cholangiopancreatography (ERCP) brushing of diseased bile duct areas and expanded as organoids using previously established culture methods. Stable CO lines were analyzed for cell type identity, basic cholangiocyte function, and transcriptomic signature. RESULTS: We demonstrate that cholangiocytes, derived from the damaged area within the bile ducts of PSC patients, can be expanded in culture without displaying functional or genetic disease-related features. We further show that COs from patients who later were diagnosed with dysplasia exhibit higher expression of the cancer-associated genes PGC, FXYD2, MIR4435-2HG, and HES1. CONCLUSIONS: Our results demonstrate that PSC organoids are largely similar to control organoids after culture and highlight the significance of COs as a tool for regenerative medicine approaches as well as their potential for discovering new potential biomarkers for diagnosing cholangiocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, endoscopic retrograde cholangiopancreatography (ERCP)-derived extrahepatic cholangiocyte organoids generated from PSCs and non-PSC patients were shown to be largely similar when cultured in vitro, notably in terms of their BEC marker expression and BEC landmark functions, and they displayed similar responses to inflammatory cytokine stimulation [176].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [176]
In the citing paper
“Finally, PSC is considered a risk factor for intrahepatic cholangiocarcinoma [176].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [176]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · cited 2×
“The ImageJ 1.48 k software [22] was used for image processing.”
MethodInfluentialIntegrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 1×
“Seurat [29] clustering, with hyper-parameters optimized on data characteristics using ClustAssess [25], revealed 13 clusters when all CO lines were evaluated together (Fig.”
MethodHafemeister, C., & Satija, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1874-1 · Cited by 4,479 · cited 1×
“15,564 cells passed all the quality control filters, across samples; post-filtering, the expression levels were normalized using SCTransform [24].”
MethodMetsalu, T., & Vilo, J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv468 · Cited by 3,709
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Self-citationBoonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725 · cited 1×
“In addition to the progressive nature of the disease leading to liver failure, the ongoing chronic inflammation within the bile ducts puts PSC patients at a high risk of developing cholangiocarcinoma (CCA) that represents a major contributor to PSC-related mortality [4].”
BackgroundCholangiocyte organoids can repair bile ducts after transplantation in the human liver
Sampaziotis, F., Muraro, D., Tysoe, O. C., Sawiak, S., Beach, T. E., Godfrey, E. M., Upponi, S. S., Brevini, T., Wesley, B. T., Garcia-Bernardo, J., et al. (2021) · Science · doi:10.1126/science.aaz6964 · Cited by 394 · cited 3×
“A previous study comparing scRNAseq data from fresh human cholangiocytes to cholangiocyte organoids demonstrated a loss of transcriptional diversity after prolonged cell culture [16].”
BackgroundSelf-citationSampaziotis, F., Justin, A. W., Tysoe, O. C., Sawiak, S., Godfrey, E. M., Upponi, S. S., Gieseck, R. L., de Brito, M. C., Berntsen, N. L., Gómez-Vázquez, M. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4360 · Cited by 296
Self-citation
Research works printed but not linked: 1
- Arash S, Munteanu A, Mohorianu I. ClustAssess: tools for assessing the robustness of single-cell clustering. bioRxiv. 2022; 2022–01.
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Molecular Basis of Na, K–ATPase Regulation of Diseases: Hormone and FXYD2 Interactions
Cordeiro, B. M., Fontes, C. F. L., & Meyer‐Fernandes, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413398 · Cited by 22
Advances in Biliary Disease Organoid Research: From Model Construction to Clinical Applications
Peng, B., Huang, M., Zhang, J., & Xiang, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501776 · Cited by 8
Applications of 3D models in cholangiocarcinoma
Montagner, A., Lemberger-Viehmann, L., Reitberger, N., Schmidt, M., Scheruebl, J., Pion, E., Wagner, B. J., Pilarsky, C. P., Grützmann, R., Aung, T., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1598552 · Cited by 7
Jalan‐Sakrikar, N., Anwar, A. A., Ali, A., Nasser‐Ghodsi, N., Felzen, A., Huebert, R. C., LaRusso, N. F., & O’Hara, S. P. (2026) · Physiological Reviews · doi:10.1152/physrev.00022.2025 · Cited by 5
Metadata
- Authors
- Frank, A. K., Chung, B. K., De Novales, M. L. L., Engesæter, L. K., Hoyle, H. W., Øgaard, J., Heslop, J., Karlsen, T. H., Tysoe, O., Brevini, T., Tchorz, J. S., Vallier, L., Mohorianu, I., Sampaziotis, F., & Melum, E.
- Affiliations
- Oslo University Hospital (NO)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Novartis (Switzerland) (CH)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Melum, Espen
- ORCID
- Venue
- Digestive Diseases and Sciences
- Published
- 2024-08-19
- Volume
- 69
- Issue
- 10
- Pages
- 3810-3823
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC11489200
- OpenAlex
- W4401691134
- Cited by
- 14
- References
- 41
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 1
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- Digestive Diseases and Sciences (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by-nc)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- Funders
- Scientia Fellowship European Union`s Horizon 2020 research and innovation program (No 801133)
- Norwegian PSC Research Center
- European Research Council (New-Chol)
- Norwegian Research council (315399)
- University of Oslo
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- primary sclerosing cholangitis, cholangiocytes, cholangiocyte organoids, bile ducts, single-cell transcriptomics, dysplasia, Hes1, PGC, FXYD2, MIR4435-2HG, regenerative medicine, endoscopic retrograde cholangiopancreatography
- MeSH terms
- Bile Ducts, Epithelial Cells, Female, Humans, Male, Organoids, Cholangitis, Sclerosing, Gene Expression Profiling, Single-Cell Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients. https://app.cochat.ai/papers/10.1007/s10620-024-08570-y
- The paper
- Frank, A. K., Chung, B. K., De Novales, M. L. L., Engesæter, L. K., Hoyle, H. W., Øgaard, J., Heslop, J., Karlsen, T. H., Tysoe, O., Brevini, T., Tchorz, J. S., Vallier, L., Mohorianu, I., Sampaziotis, F., & Melum, E. (2024). Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08570-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.